Rebecca Lynn Porter, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 5 | 2024 | 4878 | 1.070 |
Why?
|
RNA, Satellite | 1 | 2022 | 17 | 0.830 |
Why?
|
Hematopoietic Stem Cells | 6 | 2013 | 3397 | 0.540 |
Why?
|
Immunoconjugates | 1 | 2023 | 953 | 0.510 |
Why?
|
Radiation Injuries, Experimental | 1 | 2013 | 88 | 0.420 |
Why?
|
Radiation-Protective Agents | 1 | 2013 | 88 | 0.420 |
Why?
|
Dinoprostone | 2 | 2013 | 597 | 0.410 |
Why?
|
Osteoblasts | 4 | 2012 | 1143 | 0.300 |
Why?
|
Osteocytes | 1 | 2008 | 192 | 0.270 |
Why?
|
Immunotherapy | 1 | 2022 | 4652 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.260 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2417 | 0.250 |
Why?
|
Bone Marrow | 2 | 2009 | 2911 | 0.190 |
Why?
|
Hematopoiesis | 3 | 2012 | 2050 | 0.190 |
Why?
|
Cell Communication | 1 | 2008 | 1657 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13642 | 0.180 |
Why?
|
Macrophages | 1 | 2013 | 5769 | 0.150 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2022 | 738 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4431 | 0.140 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2016 | 258 | 0.110 |
Why?
|
Puerperal Disorders | 1 | 2016 | 299 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1589 | 0.100 |
Why?
|
RNA | 1 | 2022 | 2726 | 0.100 |
Why?
|
Whole-Body Irradiation | 1 | 2013 | 433 | 0.100 |
Why?
|
RNA, Antisense | 1 | 2011 | 136 | 0.090 |
Why?
|
RNA, Fungal | 1 | 2011 | 161 | 0.090 |
Why?
|
Cyclooxygenase 2 | 1 | 2013 | 597 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8528 | 0.090 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2011 | 179 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16986 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3877 | 0.080 |
Why?
|
Schizosaccharomyces | 1 | 2011 | 238 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5305 | 0.080 |
Why?
|
Methyltransferases | 1 | 2011 | 377 | 0.070 |
Why?
|
Cadherins | 1 | 2012 | 903 | 0.070 |
Why?
|
Erythroblasts | 1 | 2007 | 142 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 8552 | 0.070 |
Why?
|
Actins | 1 | 2013 | 2050 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9280 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16592 | 0.060 |
Why?
|
Erythropoiesis | 1 | 2007 | 683 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9541 | 0.050 |
Why?
|
Cell Survival | 1 | 2013 | 5791 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 470 | 0.050 |
Why?
|
RNA Interference | 1 | 2011 | 2832 | 0.050 |
Why?
|
Female | 6 | 2024 | 392686 | 0.050 |
Why?
|
Mice | 6 | 2024 | 81533 | 0.050 |
Why?
|
Humans | 8 | 2024 | 761572 | 0.050 |
Why?
|
Fetus | 1 | 2007 | 1863 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7581 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3449 | 0.040 |
Why?
|
Animals | 7 | 2024 | 168467 | 0.040 |
Why?
|
Cell Lineage | 1 | 2008 | 2556 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 2827 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2013 | 11530 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5315 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2024 | 1359 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10448 | 0.030 |
Why?
|
Apoptosis | 1 | 2013 | 9489 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3603 | 0.030 |
Why?
|
Osteoclasts | 2 | 2009 | 711 | 0.030 |
Why?
|
Peripartum Period | 1 | 2016 | 137 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1469 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13382 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 371 | 0.020 |
Why?
|
Euchromatin | 1 | 2011 | 54 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1125 | 0.020 |
Why?
|
Centromere | 1 | 2011 | 212 | 0.020 |
Why?
|
Bone and Bones | 2 | 2012 | 2568 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 352 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1626 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2012 | 581 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1084 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2011 | 416 | 0.020 |
Why?
|
Yolk Sac | 1 | 2007 | 79 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2007 | 237 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2007 | 364 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 682 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1803 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23447 | 0.010 |
Why?
|
Embryonic Development | 1 | 2007 | 721 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22172 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1897 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12990 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2011 | 1841 | 0.010 |
Why?
|
Adipocytes | 1 | 2008 | 1194 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.010 |
Why?
|
Pregnancy | 2 | 2016 | 29876 | 0.010 |
Why?
|
Histones | 1 | 2011 | 2580 | 0.010 |
Why?
|
Male | 3 | 2013 | 360842 | 0.010 |
Why?
|
Bone Density | 1 | 2012 | 3551 | 0.010 |
Why?
|
Graft Survival | 1 | 2009 | 3820 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12794 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1896 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2529 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8711 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5672 | 0.010 |
Why?
|
Neurons | 1 | 2008 | 9463 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2016 | 80646 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 30054 | 0.000 |
Why?
|
Adult | 1 | 2016 | 221203 | 0.000 |
Why?
|